Researcher Christina Caira reflects on use of AI in Parkinson’s Disease research Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by the degeneration of dopamine releasing regions in the brain....

San Jose, CA, 20th August 2019 -- OptraSCAN®, the leading end-to-end digital pathology solution provider today announced that U.S. Patent and Trademark Office (USPTO) has granted a patent to OptraSCAN’s invention, titled ‘Method of...